Biotech Sector Correction: Moving Beyond the Bubble
The recent narrative framing biotech’s current struggles as a dawn after darkness ignores a critical reality: the sector is not just emerging from a difficult period but is in fact correcting from an unsustainable bubble. The exuberance that characterized the biotech industry during the pandemic years created an inflated market that was bound to contract….